Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Spirometry | Research article

Reduced forced vital capacity is independently associated with ethnicity, metabolic factors and respiratory symptoms in a Caribbean population: a cross-sectional study

Authors: Sateesh Sakhamuri, Fallon Lutchmansingh, Donald Simeon, Liane Conyette, Peter Burney, Terence Seemungal

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

Relationships between low forced vital capacity (FVC), and morbidity have previously been studied but there are no data available for the Caribbean population. This study assessed the association of low FVC with risk factors, health variables and socioeconomic status in a community-based study of the Trinidad and Tobago population.

Methods

A cross-sectional survey was conducted using the Burden of Obstructive Lung Disease (BOLD) study protocol. Participants aged 40 years and above were selected using a two-stage stratified cluster sampling. Generalized linear models were used to examine associations between FVC and risk factors.

Results

Among the 1104 participants studied a lower post-bronchodilator FVC was independently associated with a large waist circumference (− 172 ml; 95% CI, − 66 to − 278), Indo-Caribbean ethnicity (− 180 ml; 95% CI, − 90 to − 269) and being underweight (− 185 ml; 95% CI, − 40 to − 330). A higher FVC was associated with smoking cannabis (+ 155 ml; 95% CI, + 27 to + 282). Separate analyses to examine associations with health variables indicated that participants with diabetes (p = 0∙041), history of breathlessness (p = 0∙007), and wheeze in the past 12 months (p = 0∙040) also exhibited lower post-bronchodilator FVC.

Conclusion

These findings suggest that low FVC in this Caribbean population is associated with ethnicity, low body mass index (BMI), large waist circumference, chronic respiratory symptoms, and diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011;66(1):49–54.CrossRef Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011;66(1):49–54.CrossRef
2.
go back to reference Magnussen C, Ojeda FM, Rzayeva N, et al. FEV1 and FVC predict all-cause mortality independent of cardiac function — results from the population-based Gutenberg health study. Int J Cardiol. 2017;234:64–8.CrossRef Magnussen C, Ojeda FM, Rzayeva N, et al. FEV1 and FVC predict all-cause mortality independent of cardiac function — results from the population-based Gutenberg health study. Int J Cardiol. 2017;234:64–8.CrossRef
3.
go back to reference Gupta RP, Strachan DP. Ventilatory function as a predictor of mortality in lifelong non-smokers: evidence from large British cohort studies. BMJ Open. 2017;7(7):e015381.CrossRef Gupta RP, Strachan DP. Ventilatory function as a predictor of mortality in lifelong non-smokers: evidence from large British cohort studies. BMJ Open. 2017;7(7):e015381.CrossRef
4.
go back to reference Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol. 2003;158:1171–81.CrossRef Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol. 2003;158:1171–81.CrossRef
5.
go back to reference Mannino DM, Davis KJ, Disantostefano RL. Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort. Respirology. 2013;18(7):1083–8.PubMed Mannino DM, Davis KJ, Disantostefano RL. Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort. Respirology. 2013;18(7):1083–8.PubMed
6.
go back to reference Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605.CrossRef Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605.CrossRef
7.
go back to reference Kurl S, Jae SY, Kauhanen J, et al. Impaired pulmonary function is a risk predictor for sudden cardiac death in men. Ann Med. 2015;47(5):381–5.CrossRef Kurl S, Jae SY, Kauhanen J, et al. Impaired pulmonary function is a risk predictor for sudden cardiac death in men. Ann Med. 2015;47(5):381–5.CrossRef
8.
go back to reference Lee HM, Chung SJ, Lopez VA, et al. Association of FVC and total mortality in US adults with metabolic syndrome and diabetes. Chest. 2009;136(1):171–6.CrossRef Lee HM, Chung SJ, Lopez VA, et al. Association of FVC and total mortality in US adults with metabolic syndrome and diabetes. Chest. 2009;136(1):171–6.CrossRef
9.
go back to reference Engström G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253(5):574–81.CrossRef Engström G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253(5):574–81.CrossRef
10.
go back to reference Yeh HC, Punjabi NM, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(6):1472–9.CrossRef Yeh HC, Punjabi NM, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(6):1472–9.CrossRef
11.
go back to reference Sumida K, Kwak L, Grams ME, et al. Lung function and incident kidney disease: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2017;70(5):675–85.CrossRef Sumida K, Kwak L, Grams ME, et al. Lung function and incident kidney disease: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2017;70(5):675–85.CrossRef
12.
go back to reference Seemungal T, Harrinarine R, Rios M, et al. Obstructive lung disease in acute medical patients. West Indian Med J. 2008;57:7–14.PubMed Seemungal T, Harrinarine R, Rios M, et al. Obstructive lung disease in acute medical patients. West Indian Med J. 2008;57:7–14.PubMed
13.
go back to reference Thorington P, Rios M, Avila G, et al. Prevalence of chronic obstructive pulmonary disease among stable chronic disease subjects in primary care in Trinidad, West Indies. J Thorac Dis. 2011;3(3):177–82.PubMedPubMedCentral Thorington P, Rios M, Avila G, et al. Prevalence of chronic obstructive pulmonary disease among stable chronic disease subjects in primary care in Trinidad, West Indies. J Thorac Dis. 2011;3(3):177–82.PubMedPubMedCentral
14.
go back to reference Pinto Pereira LM, Seemungal TAR, Teelucksingh S, et al. Restrictive pulmonary deficit is associated with inflammation in sub-optimally controlled obese diabetics. J Thorac Dis. 2013;5(3):289–97.PubMedPubMedCentral Pinto Pereira LM, Seemungal TAR, Teelucksingh S, et al. Restrictive pulmonary deficit is associated with inflammation in sub-optimally controlled obese diabetics. J Thorac Dis. 2013;5(3):289–97.PubMedPubMedCentral
15.
go back to reference Linares-Perdomo O, Hegewald M, Collingridge DS, et al. Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity. Eur Respir J. 2016;48(1):133–41.CrossRef Linares-Perdomo O, Hegewald M, Collingridge DS, et al. Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity. Eur Respir J. 2016;48(1):133–41.CrossRef
16.
go back to reference Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study Lancet. 2013;384(9945):766–81. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study Lancet. 2013;384(9945):766–81.
18.
go back to reference Townend J, Minelli C, Harrabi I, et al. Development of an international scale of socio-economic position based on household assets. Emer Themes Epidemiol. 2015;12:13.CrossRef Townend J, Minelli C, Harrabi I, et al. Development of an international scale of socio-economic position based on household assets. Emer Themes Epidemiol. 2015;12:13.CrossRef
19.
go back to reference American Thoracic Society Statement. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–36.CrossRef American Thoracic Society Statement. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–36.CrossRef
20.
go back to reference Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD. 2005;2(2):277–83.CrossRef Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD. 2005;2(2):277–83.CrossRef
21.
go back to reference Hankinson JL, Eschenbacher B, Townsend M, et al. Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test. Eur Respir J. 2015;45(5):1283–92.CrossRef Hankinson JL, Eschenbacher B, Townsend M, et al. Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test. Eur Respir J. 2015;45(5):1283–92.CrossRef
22.
go back to reference Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179–87.CrossRef Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179–87.CrossRef
23.
go back to reference Duong M, Islam S, Rangarajan S, et al. Global differences in lung function by region (PURE): an international, community-based prospective study. Lancet Respir Med. 2013;1:599–609.CrossRef Duong M, Islam S, Rangarajan S, et al. Global differences in lung function by region (PURE): an international, community-based prospective study. Lancet Respir Med. 2013;1:599–609.CrossRef
24.
go back to reference Coates AL, Wong SL, Tremblay C, et al. Reference equations for spirometry in the Canadian population. Ann Am Thorac Soc. 2016;13(6):833–41.CrossRef Coates AL, Wong SL, Tremblay C, et al. Reference equations for spirometry in the Canadian population. Ann Am Thorac Soc. 2016;13(6):833–41.CrossRef
25.
go back to reference Obaseki DO, Erhabor GE, Awopeju OF, et al. Reduced forced vital capacity in an African population. Prevalence and risk factors. Ann Am Thorac Soc. 2017;14(5):714–21.CrossRef Obaseki DO, Erhabor GE, Awopeju OF, et al. Reduced forced vital capacity in an African population. Prevalence and risk factors. Ann Am Thorac Soc. 2017;14(5):714–21.CrossRef
26.
go back to reference Kurth L, Hnizdo E. Change in prevalence of restrictive lung impairment in the U.S. population and associated risk factors: the National Health and nutrition examination survey (NHANES) 1988–1994 and 2007–2010. Multidiscip Respir Med. 2015;10:7.CrossRef Kurth L, Hnizdo E. Change in prevalence of restrictive lung impairment in the U.S. population and associated risk factors: the National Health and nutrition examination survey (NHANES) 1988–1994 and 2007–2010. Multidiscip Respir Med. 2015;10:7.CrossRef
27.
go back to reference Thyagarajan B, Jacobs DR Jr, Apostol GG, et al. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res. 2008;9:31.CrossRef Thyagarajan B, Jacobs DR Jr, Apostol GG, et al. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res. 2008;9:31.CrossRef
28.
go back to reference Chen Y, Rennie D, Cormier YF, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr. 2007;85(1):35–9.CrossRef Chen Y, Rennie D, Cormier YF, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr. 2007;85(1):35–9.CrossRef
29.
go back to reference Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care. 2007;30(6):1647–52.CrossRef Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care. 2007;30(6):1647–52.CrossRef
30.
go back to reference Saad NJ, Patel J, Burney P, et al. Birth weight and lung function in adulthood: a systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(6):994–1004.CrossRef Saad NJ, Patel J, Burney P, et al. Birth weight and lung function in adulthood: a systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(6):994–1004.CrossRef
31.
go back to reference Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42–7.CrossRef Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42–7.CrossRef
32.
go back to reference Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and nutrition examination study. Ann Am Thorac Soc. 2015;12(2):135–41.CrossRef Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and nutrition examination study. Ann Am Thorac Soc. 2015;12(2):135–41.CrossRef
33.
go back to reference Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA. 2012;307(2):173–81.CrossRef Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA. 2012;307(2):173–81.CrossRef
34.
go back to reference Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973;289(7):336–41.CrossRef Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973;289(7):336–41.CrossRef
35.
go back to reference Hii SW, Tam JDC, Thompson BR, et al. Bullous lung disease due to marijuana. Respirology. 2008;13(1):122–7.CrossRef Hii SW, Tam JDC, Thompson BR, et al. Bullous lung disease due to marijuana. Respirology. 2008;13(1):122–7.CrossRef
36.
go back to reference Amaral AFS, Patel J, Kato BS, et al. Airflow obstruction and use of solid fuels for cooking or heating: BOLD results. Am J Respir Crit Care Med. 2018;197(5):595–610.CrossRef Amaral AFS, Patel J, Kato BS, et al. Airflow obstruction and use of solid fuels for cooking or heating: BOLD results. Am J Respir Crit Care Med. 2018;197(5):595–610.CrossRef
37.
go back to reference Grønseth R, Vollmer WM, Hardie JA, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610–20.CrossRef Grønseth R, Vollmer WM, Hardie JA, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610–20.CrossRef
38.
go back to reference Soriano JB, Miravitlles M, García-Río F, et al. Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J. 2012;21(2):187–93.CrossRef Soriano JB, Miravitlles M, García-Río F, et al. Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J. 2012;21(2):187–93.CrossRef
39.
go back to reference van den Borst B, Gosker HR, Zeegers MP, et al. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393–406.CrossRef van den Borst B, Gosker HR, Zeegers MP, et al. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393–406.CrossRef
40.
go back to reference Townend J, Minelli C, Mortimer K, et al. The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J. 2017;49(6):1601880.CrossRef Townend J, Minelli C, Mortimer K, et al. The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J. 2017;49(6):1601880.CrossRef
Metadata
Title
Reduced forced vital capacity is independently associated with ethnicity, metabolic factors and respiratory symptoms in a Caribbean population: a cross-sectional study
Authors
Sateesh Sakhamuri
Fallon Lutchmansingh
Donald Simeon
Liane Conyette
Peter Burney
Terence Seemungal
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Spirometry
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0823-9

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue